This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Understanding what to look for in rewards programs can enhance your benefits. Explore essential factors to make informed choices.
17,647 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
California is backing electric vehicle buyers with a new point-of-sale rebate program. For Rivian, this policy shift ...
Urban air mobility could redefine city travel, and Archer Aviation sits at the center of that promise. This guide bre...
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Tired of watching your grocery receipts grow? This guide delivers proven cheap grocery shopping tips you can put into...
Greystone Real Estate Capital closes its second LIHTC-focused fund at 137 million, expanding its LIHTC equity to over...
A new $150 million startup thinks real world connection can counter online detachment. This report examines the plan,...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
A biotech name drops sharply after mixed obesity data, sending Wave Life Sciences and the broader market into a brief...
As pharmacy discounts proliferate, insured customers may chase lower prices at the counter only to discover long-term...
A sweeping housing proposal could unlock an easier path to ownership for many Americans. This guide breaks down what ...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...